Primary Site >> Liver Cancer

Gene >> ARHGAP9

  • 1982
  • 1990
  • 1994
  • 2002
  • 2011
  • 2012
  • 2016
  • 2017
  • 2018
Ref: DNA content of liver cell nuclei of N-2-fluorenylacetamide-induced altered foci and neoplasms in rats and human hyperplastic foci.
PMID: 6958905
Ref: Effects of thermotherapy on the morphology and cell cycle of a transplanted ascites hepatoma in rats.
PMID: 2352343
Ref: Differentiation-specific transcriptional regulation of the hepatitis B virus nucleocapsid gene in human hepatoma cell lines.
PMID: 8009854
Ref: Development of viral disinfectant assays for duck hepatitis B virus using cell culture/PCR.
PMID: 12367728
Ref: Design, synthesis and biological evaluation of novel 4-thiazolidinones containing indolin-2-one moiety as potential antitumor agent.
PMID: 21621880
Ref: Chemical modification and anticancer effect of prenylated flavanones from Taiwanese propolis.
PMID: 21790499
Ref: Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents.
PMID: 26686931
Ref: Antitumor Activities of the Novel Isosteviol Derivative 10C Against Liver Cancer.
PMID: 28373419
Ref: Synthesis, Cytotoxic and Anti-proliferative Activity of Novel Thiophene, Thieno[2,3-b]pyridine and Pyran Derivatives Derived from 4,5,6,7-tetrahydrobenzo[b]thiophene Derivative.
PMID: 28380235
Ref: Pyrrolizines: Design, synthesis, anticancer evaluation and investigation of the potential mechanism of action.
PMID: 28916158
Ref: Synthesis, antitumor activity evaluation, and DNA-binding study of coumarin-based agents.
PMID: 29148081
Ref: ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2/E-cadherin.
PMID: 30206221